Intentar ORO - Gratis
Border Plus launches India's first national standardised exam for nurses seeking international careers
Bio Spectrum
|July 2026
BorderPlus, a Mumbai-based global talent mobility platform, has announced the launch of B.R.I.D.G.E (Border Plus International Deployment and Global Mobility Exam), the country's first standardised national examination designed to assess and prepare Indian nurses for international placement, with a primary focus on career opportunities abroad. B.R.I.D.G.E introduces a merit-based scholarship model with a total pool worth Rs 1 crore+, designed to directly reduce the cost of training the nurses are required to undergo to upskill themselves for an international career.
-
The exam is structured across three sections: Basic Clinical Skills, which tests foundational nursing knowledge includ
Esta historia es de la edición July 2026 de Bio Spectrum.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Bio Spectrum
Bio Spectrum
“The N-FIS market is no longer emerging; it's aligning with where healthcare is headed”
Once viewed as a niche innovation, Needle-Free Injection System (N-FIS) are now evolving into a multi-therapy drug delivery solution, with growing applications across paediatrics, vaccination, in vitro fertilisation (IVF), pain management, and the rapidly expanding GLP-1 therapy segment.
5 mins
July 2026
Bio Spectrum
Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing
Imaging Endpoints, a Hyderabad-based oncologyfocused imaging contract research organisation (CRO), has appointed Srikanth Ayyappan as Associate Vice President (AVP), Global Marketing.
1 min
July 2026
Bio Spectrum
Cytiva introduces next-gen Biacore 8 series SPR systems for drug discovery
US-based Cytiva, a Danaher company, is introducing the next generation of its Biacore 8 series SPR systems, enabling scientists to generate reliable interaction data faster, as drug discovery grows more complex.
1 min
July 2026
Bio Spectrum
Decentralization and Fragmentation in Bioprocessing Industry
The global bioprocessing industry is undergoing a fundamental transformation.
2 mins
July 2026
Bio Spectrum
Vijay TS steps in as CPO at Redcliffe Labs
Noida-based Redcliffe Labs has announced the appointment of Vijay T. S. as Chief People Officer (CPO), as the company continues to strengthen its organisational foundation to support its next phase of growth and expansion across India.
1 min
July 2026
Bio Spectrum
Dr Sanjay Chaturvedi takes charge as CEO at Matrix Pharmacorn
Telangana-based Matrix Pharmacorp has announced the appointment of Dr Sanjay Chaturvedi as Chief Executive Officer (CEO).
1 min
July 2026
Bio Spectrum
How Mergers and Acquisitions Spell Success for Pharma Companies
The recent acquisition of Organon by Sun Pharmaceutical Industries marks one of the largest pharmaceutical deals involving an Indian company. The all-cash transaction, valued at approximately $11.75 billion, highlights the growing global ambitions of Indian pharmaceutical firms. The latest mergers and acquisitions (M&A) have emerged as a strategic tool for pharmaceutical companies to strengthen market presence, what the future holds and the associated risks. However, challenges remain. Let us delve deep into what goes into these huge M&A transactions and what can be the likely challenges.
6 mins
July 2026
Bio Spectrum
Align Technology to open multi-million dollar manufacturing facility in Hyderabad
Align Technology, Inc., a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero intraoral scanners and services, and exocad CAD/ CAM software for digital orthodontics and restorative dentistry, has announced plans to open a new manufacturing facility in Hyderabad, in 2027, create more than 300 direct jobs, and spend approximately $200 million in both capital and operational expense over the next several years.
1 min
July 2026
Bio Spectrum
Pharma Fermentation: India's Next Biomanufacturing Opportunity
Driven by increasing demand for biologics, antibiotics, enzymes, biosimilars, and services offered by Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Development and Manufacturing Organisations (CRDMOs), the Indian pharmaceutical fermentation market is witnessing strong growth. The industry is gradually shifting from the production of traditional generic medicines toward higher-value, fermentation-based products, reflecting the growing importance of complex biologics and advanced therapeutics. According to IMARC Group, the India fermentation chemicals market reached $3.2 billion in 2025 and is projected to grow to $5.5 billion by 2034, exhibiting a CAGR of 5.79 per cent during 2026-2034. However, growth alone will not guarantee leadership. India’s ability to build a robust domestic fermentation ecosystem, reduce import dependence, and scale advanced biomanufacturing capabilities will determine whether it can emerge as a global fermentation hub. Let's explore further.
7 mins
July 2026
Bio Spectrum
GVRP & StepsBio unveil new formulations R&D centre in Bengaluru
GVRP (GV Research Platform), a Hyderabadbased research organisation, has announced the inauguration of the GVRP Steps Bio Research Centre (GSRC), a strategic collaboration with Bengalurubased startup Steps Biosciences that marks a significant milestone in India's pharmaceutical R&D landscape.
1 min
July 2026
Listen
Translate
Change font size